| top | |
| BRAINLIFE NEWSLETTER | |
Volume 3, Number 13 - 10 May
2004 |
|
|
|
|
|
Contents |
|
|
|
|
| Etiology & Pathogenesis | |
| Overall Management | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Jung HL, Wang KC, Kim SK, Sung KW, Koo HH,
Shin HY, Ahn HS, Shin HJ, Cho BK Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas J Neurooncol. 2004 Mar-Apr;67(1-2):41-6. |
|
|
Kasumi Araki, Kazuhiko Nozaki,
Tetsuya Ueba, Masaaki Tatsuka and Nobuo Hashimoto High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas J Neurooncol. 2004 Mar-Apr;67(1-2):53-64. |
|
|
Mentlein R, Forstreuter F, Mehdorn HM, Held-Feindt J Functional significance of vascular endothelial growth factor receptor expression on human glioma cells J Neurooncol. 2004 Mar-Apr;67(1-2):9-18. |
|
|
Strege RJ, Godt C, Stark AM, Hugo HH, Mehdorn HM Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas J Neurooncol. 2004 Mar-Apr;67(1-2):29-39. |
|
|
|
|
|
|
|
|
|
|
|
Ji-Young Jeon, Hyeong-Joong
Yi, Seung-Ro Lee, Seung-Sam Paik and Kwang-Soo Lee Skull metastasis from ampulla of Vater adenocarcinoma: case report J Neurooncol. 2004 Mar-Apr;67(1-2):107-13. |
|
|
Tsugumichi Ichioka,
Shin-Ichi Miyatake, Naoki Asai, Yoshinaga Kajimoto, Toshimasa Nakagawa,
Hideyuki Hayashi and Toshihiko Kuroiwa Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate J Neurooncol. 2004 Mar-Apr;67(1-2):47-52. |
|
|
|
|
|
|
|
|
|
|
| S. Chibbaro,
L. Benvenuti, A. Caprio, S. Carnesecchi, F. Pulerà, F. Faggionato, D.
Serino, C. Galli, M. Andreuccetti, N. Buxton and R. Gagliardi Temozolomide as first-line agent in treating high-grade gliomas: phase II study J Neurooncol. 2004 Mar-Apr;67(1-2):77-81. |
|
|
L.K. Csatary,
G. Gosztonyi, J. Szeberenyi, Z. Fabian, V. Liszka, B. Bodey and C.M.
Csatary |
|
|
Elisabetta Donzelli, Maria
Carfì, Mariarosaria Miloso, Alberto Strada, Stefania Galbiati, Martine
Bayssas, Genevieve Griffon-Etienne, Guido Cavaletti, Maria Grazia
Petruccioli and Giovanni Tredici Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y J Neurooncol. 2004 Mar-Apr;67(1-2):65-73. |
|
|
Elpis Mantadakis, Maria Raissaki,
Vassiliki Danilatou, Alexander Kambourakis, Eftichia Stiakaki and Maria Kalmanti Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review J Neurooncol. 2004 Mar-Apr;67(1-2):95-100. |
|
| Antonio
Pérez-Martínez, Victor Quintero, Marta González Vicent, Julián
Sevilla, Miguel Ángel Díaz and Luis Madero High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors J Neurooncol. 2004 Mar-Apr;67(1-2):101-6. |
|
|
Perez Martinez A, Contra T, Scaglione C, Diaz Perez MA,
Madero Lopez L Topotecan for pediatric patients with resistant and recurrent solid tumors  An Pediatr
(Barc). 2003 Aug;59(2):143-8. |
|
|
Cheppail Ramachandran, Ziad Khatib,
Athena Pefkarou, John Fort, Hugo B. Fonseca, Steven J. Melnick and Enrique
Escalon Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells J Neurooncol. 2004 Mar-Apr;67(1-2):19-28. |
|
|
Vitaly E. Siomin, Michael A.
Vogelbaum, Andrew A. Kanner, Shih-Yuan Lee, John H. Suh and Gene H. Barnett Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery J Neurooncol. 2004 Mar-Apr;67(1-2):115-21. |
|
